Skip to Content

W 273 (Lamotrigine Extended-Release 100 mg)

Pill with imprint W 273 is Brown, Round and has been identified as Lamotrigine Extended-Release 100 mg. It is supplied by Wockhardt USA LLC.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; anxiety; seizure prevention; borderline personality disorder (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for W 273

Lamotrigine extended-release 100 mg W 273

Lamotrigine Extended-Release

Imprint:
W 273
Strength:
100 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Wockhardt USA LLC
Inactive Ingredients:
diethyl phthalate
ferric oxide red
ferric oxide yellow
hypromelloses
lactose monohydrate
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol
magnesium silicate
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide